Barry Greene served as chief executive officer of Sage Therapeutics from December 2020 to July 2025.
Barry Greene served as chief executive officer of Sage Therapeutics from December 2020 to July 2025, where he focused on brain health disorders and led the launch of a postpartum depression treatment. Prior to Sage, he spent nearly two decades at Alnylam Pharmaceuticals, building it into a multi-product biopharmaceutical organization.
Full founder directory · Investor directory · Company funding database · Fundraising library